Tag: clinical results

November 25, 2018

What is In-licensing?

In-licensing may be pharma’s preferred mode of business development these days. Should that impact your investment strategy?
July 2, 2018

4 Top Pharma Stocks on the TSX of Q2 2018

As investors look ahead to the remainder of 2018, we've put together a list of the top-gaining pharmaceutical stocks on...
June 28, 2018

5 Top NASDAQ Genetic Stocks of Q2 2018

In the final days of Q2 2018, we've profiled the five top NASDAQ genetic stocks year-to-date. Here's a look at...
May 7, 2018

Krystal Biotech Reports First Quarter 2018 Financial Results and Provides Corporate Update

Krystal Biotech (NASDAQ:KRYS), a gene therapy company advancing “off-the-shelf” topical and intra-dermal treatments for dermatological diseases, today reports financial results for...
April 30, 2018

Key Stock Catalysts in the FDA Drug Application Process

Pharmaceutical and biotech companies in the US must follow a standard process to advance a new drug candidate through nonclinical...
April 29, 2018

5 Top Weekly NASDAQ Biotech Stocks: Eleven Biotherapeutics Up 45 Percent

Eleven Biotherapeutics, EyePoint Pharmaceuticals, Avid Bioservices, Cerecor and Celldex were last week's top gainers on the NASDAQ.
April 3, 2018

BriaCell’s Lead Product Candidate Mechanism of Action Described in a Major Immunology Journal

BriaCell Therapeutics Corp. ("BriaCell") (TSXV:BCT) (OTCQB:BCTXF), an immuno-oncology focused biotechnology company with a proprietary targeted immunotherapy technology, is pleased to...